We are live on ! Find out more
TAK icon

Takeda Pharmaceutical
TAK

390 hedge funds and large institutions have $3.64B invested in Takeda Pharmaceutical in 2019 Q1 according to their latest regulatory filings, with 308 funds opening new positions, 62 increasing their positions, 14 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,322% more first-time investments, than exits

New positions opened: 308 | Existing positions closed: 9

1,500% more funds holding in top 10

Funds holding in top 10: 1 → 16 (+15)

343% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 14

319% more funds holding

Funds holding: 93 → 390 (+297)

300% more capital invested

Capital invested by funds: $910M → $3.64B (+$2.73B)

4.64% more ownership

Funds ownership: 6.8% → 11.43% (+4.6%)

1% less call options, than puts

Call options by funds: $94.4M | Put options by funds: $95.5M

Holders
390
Holders Change
+297
Holders Change %
+319.35%
% of All Funds
8.44%
Holding in Top 10
16
Holding in Top 10 Change
+15
Holding in Top 10 Change %
+1,500%
% of All Funds
0.35%
New
308
Increased
62
Reduced
14
Closed
9
Calls
$94.4M
Puts
$95.5M
Net Calls
-$1.07M
Net Calls Change
-$4.21M

Top Buyers

Rank Fund Capital Flow
1
GCM
Glenview Capital Management
New York
+$525M
2
PC
Paulson & Co
New York
+$267M
3
BG
Baupost Group
Massachusetts
+$215M
4
AC
Adelphi Capital
United Kingdom
+$187M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$152M

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$200M
2
Citigroup
Citigroup
New York
-$127M
3
Bank of America
Bank of America
North Carolina
-$90.5M
4
Goldman Sachs
Goldman Sachs
New York
-$47.1M
5
CS
Credit Suisse
Switzerland
-$23.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
MIS
101
Morningstar Investment Services
Illinois
$2.43M +$2.4M +119,093 New
SM
102
SG3 Management
Puerto Rico
$2.27M +$2.24M +111,550 New
EGA
103
Eagle Global Advisors
Texas
$2.13M +$2.11M +104,672 New
MME
104
Meag Munich Ergo
Germany
$2.02M +$1.97M +97,965 New
TWI
105
Thomas White International
Illinois
$2.02M +$1.99M +99,070 New
Capital Fund Management (CFM)
106
Capital Fund Management (CFM)
France
$1.97M +$1.95M +96,706 New
State Street
107
State Street
Massachusetts
$1.93M +$1.25M +62,171 +190%
Pacer Advisors
108
Pacer Advisors
Pennsylvania
$1.9M -$38K -1,887 -2%
Truist Financial
109
Truist Financial
North Carolina
$1.86M +$586K +29,105 +47%
DAC
110
Dividend Assets Capital
South Carolina
$1.86M +$1.84M +91,323 New
FIA
111
FNY Investment Advisers
New York
$1.71M +$1.69M +84,146 New
RC
112
RegentAtlantic Capital
New Jersey
$1.68M +$1.66M +82,523 New
Wells Fargo
113
Wells Fargo
California
$1.64M +$1.39M +69,076 +608%
FCH
114
Freestone Capital Holdings
Washington
$1.63M +$1,000K +49,691 +165%
Geode Capital Management
115
Geode Capital Management
Massachusetts
$1.61M +$637K +31,672 +67%
Bank of Montreal
116
Bank of Montreal
Ontario, Canada
$1.57M +$1.55M +77,131 New
AAIM
117
American Assets Investment Management
California
$1.56M +$1.52M +75,510 New
TAM
118
TFG Asset Management
Cayman Islands
$1.5M +$1.48M +73,661 New
HCMT
119
Highland Capital Management (Texas)
Texas
$1.49M +$1.47M +72,993 New
Canada Pension Plan Investment Board
120
Canada Pension Plan Investment Board
Ontario, Canada
$1.45M +$1.44M +71,316 New
Invesco
121
Invesco
Georgia
$1.42M +$1.4M +69,557 New
Rockefeller Capital Management
122
Rockefeller Capital Management
New York
$1.22M +$1.2M +59,687 New
GI
123
GAMCO Investors
Connecticut
$1.21M +$1.2M +59,542 New
CP
124
Covenant Partners
Tennessee
$1.2M +$111K +5,492 +10%
AIA
125
Avalon Investment & Advisory
Texas
$1.18M +$1.17M +58,089 New
3 4
5
6 7

TAK Hedge Fund Activity: Q1 2019 in Review

390 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Takeda Pharmaceutical (TAK) for Q1 2019, worth a combined $3.64B — up 300% from $910M a quarter earlier.

Buyers outnumbered sellers: 308 funds opened new TAK positions and 9 closed out — a net gain of 299 holders — while 62 added to existing stakes and 14 trimmed.

The largest buyer was Glenview Capital Management, opening a new position worth an estimated $525M. The largest seller was UBS Group, cutting an estimated $200M.

  • 390 institutional investors held Takeda Pharmaceutical (TAK) as of Q1 2019, up from 93 in Q4 2018.
  • Funds reported $3.64B of Takeda Pharmaceutical stock for Q1 2019, up 300% quarter-over-quarter.
  • 308 funds opened new Takeda Pharmaceutical positions in Q1 2019 and 9 closed out, a net change of +299 holders.
  • The largest Takeda Pharmaceutical buyer in Q1 2019 was Glenview Capital Management, an estimated $525M added.
  • The largest Takeda Pharmaceutical seller in Q1 2019 was UBS Group, an estimated $200M sold.

Based on aggregated 13F filings for Q1 2019.